Advancements in Cancer and Diverse Therapies—Review

Anna Drabczyk,Sonia Kudłacik-Kramarczyk,Mateusz Jamroży,Marcel Krzan
DOI: https://doi.org/10.3390/ijms25063126
IF: 5.6
2024-03-09
International Journal of Molecular Sciences
Abstract:Nano-sized biomaterials are innovative drug carriers with nanometric dimensions. Designed with biocompatibility in mind, they enable precise drug delivery while minimizing side effects. Controlled release of therapeutic substances enhances efficacy, opening new possibilities for treating neurological and oncological diseases. Integrated diagnostic-therapeutic nanosystems allow real-time monitoring of treatment effectiveness, which is crucial for therapy personalization. Utilizing biomaterials as nano-sized carriers in conjunction with drugs represents a promising direction that could revolutionize the field of pharmaceutical therapy. Such carriers represent groundbreaking drug delivery systems on a nanometric scale, designed with biocompatibility in mind, enabling precise drug delivery while minimizing side effects. Using biomaterials in synergy with drugs demonstrates significant potential for a revolutionary impact on pharmaceutical therapy. Conclusions drawn from the review indicate that nano-sized biomaterials constitute an innovative tool that can significantly improve therapy effectiveness and safety, especially in treating neurological and oncological diseases. These findings should guide researchers towards further studies to refine nano-sized biomaterials, assess their effectiveness under various pathological conditions, and explore diagnostic-therapeutic applications. Ultimately, these results underscore the promising nature of nano-sized biomaterials as advanced drug carriers, ushering in a new era in nanomedical therapy.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the limitations of traditional drug - delivery methods in treating neurological and oncology diseases, such as low bioavailability, toxicity and side effects caused by non - specific distribution, etc. Specifically, the paper explores the application of nanomaterials as drug carriers, aiming to achieve precise drug delivery by designing biocompatible nano - sized biomaterials while reducing side effects. These nanomaterials can respond to specific stimuli (such as pH value, temperature, redox potential, enzymes, light and ultrasonic waves), thereby achieving controlled release of drugs. In addition, these materials can penetrate biological barriers, such as the blood - brain barrier, which opens up new possibilities for treating neurological or tumor diseases. The paper also emphasizes the advantages of combining biomaterials with drugs, especially their ability to precisely deliver therapeutic substances to target sites in the body. For example, using nanotechnology can improve the bioavailability of therapeutic substances and eliminate the problem of their non - specific distribution in the body. This is particularly important for anti - cancer treatment, because traditional anti - cancer drugs often damage healthy cells and produce adverse side effects. Therefore, exploring new drug - delivery strategies using nanotechnology and biomaterials to improve treatment effects and reduce adverse reactions has become a key research area. In summary, this paper aims to solve the problems existing in the current drug - delivery systems by studying the application of nano - sized biomaterials in drug delivery, especially in terms of improving treatment effects and safety.